What is the price target for SHL stock?
28 analysts have analysed SHL.DE and the average price target is 54.21 EUR. This implies a price increase of 55.43% is expected in the next year compared to the current price of 34.88.
FRA:SHL • DE000SHL1006
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for SIEMENS HEALTHINEERS AG (SHL.DE).
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2022-12-02 | Berenberg Capital Markets | Maintains | |
| 2022-11-23 | Jefferies Financial LLC | Initiate | |
| 2022-11-08 | Berenberg Capital Markets | Initiate | |
| 2022-10-18 | Jefferies Financial LLC | Initiate | |
| 2022-10-04 | Barclays | Initiate | |
| 2022-08-25 | UBS | Initiate | |
| 2022-08-19 | JP Morgan & Company | Initiate | |
| 2022-08-04 | Barclays | Initiate | |
| 2022-05-31 | Barclays | Initiate | |
| 2022-05-25 | JP Morgan & Company | Initiate | |
| 2022-04-04 | Berenberg Capital Markets | Initiate | |
| 2022-03-31 | Deutsche Bank Capital | Initiate | |
| 2022-03-30 | Jefferies Financial LLC | Initiate | |
| 2022-03-30 | JP Morgan & Company | Initiate | |
| 2022-03-24 | Goldman Sachs | Initiate | |
| 2022-02-07 | JP Morgan | Initiate | |
| 2022-02-03 | Sanford Bernstein | Initiate | |
| 2022-01-21 | Goldman Sachs | Initiate | |
| 2022-01-20 | Jefferies | Initiate | |
| 2021-12-17 | Barclays | Initiate | |
| 2021-11-23 | Berenberg Bank | Initiate | |
| 2021-11-23 | Jefferies | Initiate | |
| 2021-11-19 | Kepler Cheuvreux | Initiate | |
| 2021-11-18 | Deutsche Bank | Initiate | |
| 2021-11-18 | JP Morgan | Initiate |
| 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | ||
|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 21.68B -0.16% | 22.363B 3.15% | 23.375B 4.53% | 24.187B 3.47% | 25.663B 6.10% | 27.234B 6.12% | 28.285B 3.86% | 29.991B 6.03% | |
| EBITDA YoY % growth | 3.689B -13.57% | 4.032B 9.30% | 4.46B 10.62% | 4.881B 9.44% | 5.412B 10.88% | 5.94B 9.76% | 6.348B 6.87% | 6.767B 6.60% | |
| EBIT YoY % growth | 2.132B -27.11% | 2.809B 31.75% | 3.164B 12.64% | 3.724B 17.70% | 4.2B 12.78% | 4.769B 13.55% | 5.331B 11.78% | 5.646B 5.91% | |
| Operating Margin | 9.83% | 12.56% | 13.54% | 15.40% | 16.37% | 17.51% | 18.85% | 18.83% | |
| EPS YoY % growth | 2.01 -12.61% | 2.23 10.95% | 2.39 7.17% | 2.33 -2.64% | 2.65 13.80% | 2.98 12.53% | 3.19 7.20% | 3.52 10.06% |
All data in EUR
| Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|
| EPS Q2Q % growth | 0.50 -10.72% | 0.57 -11.62% | 0.72 5.85% |
| Revenue Q2Q % growth | 6.02B 1.88% | 5.749B 1.54% | 6.921B 9.47% |
| EBITDA Q2Q % growth | 1.098B -24.69% | 1.177B -31.61% | 1.408B -35.65% |
| EBIT Q2Q % growth | 911.98M 8.44% | 928.23M 26.63% | 1.201B 34.64% |
All data in EUR
28 analysts have analysed SHL.DE and the average price target is 54.21 EUR. This implies a price increase of 55.43% is expected in the next year compared to the current price of 34.88.
SIEMENS HEALTHINEERS AG (SHL.DE) will report earnings on 2026-05-07.
The consensus EPS estimate for the next earnings of SIEMENS HEALTHINEERS AG (SHL.DE) is 0.5 EUR and the consensus revenue estimate is 6.02B EUR.
The number of analysts covering SIEMENS HEALTHINEERS AG (SHL.DE) is 28.